1 – 10 of 465
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
- Revised risk estimation and treatment stratification of low- and intermediate-risk neuroblastoma patients by integrating clinical and molecular prognostic markers
- Refinement of the critical 2p25.3 deletion region: the role of MYT1L in intellectual disability and obesity
- 2014
- Juvenile myelomonocytic leukaemia: the quest for more specific therapies
- Characterization of a set of tumor suppressor microRNAs in T cell acute lymphoblastic leukemia
- ViVar: a comprehensive platform for the analysis and visualization of structural genomic variation
- ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia
- Differential module analysis in neuroblastoma regulatory networks
- Genome dynamics of the human embryonic kidney 293 lineage in response to cell biology manipulations
- Emergence of new ALK mutations at relapse of neuroblastoma
- ABT-199 mediated inhibition of BCL2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia